Last10K.com

Item 9 Labs Corp. (INLB) SEC Filing 10-Q Quarterly Report for the period ending Friday, December 31, 2021

Item 9 Labs Corp.

CIK: 1500123 Ticker: INLB
Cover - shares
3 Months Ended
Dec. 31, 2021
Feb. 14, 2022
Cover [Abstract]  
Document Type10-Q 
Amendment Flagfalse 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Document Period End DateDec. 31, 2021 
Document Fiscal Period FocusQ1 
Document Fiscal Year Focus2022 
Current Fiscal Year End Date--09-30 
Entity File Number000-54730 
Entity Registrant NameITEM 9 LABS CORP. 
Entity Central Index Key0001500123 
Entity Tax Identification Number96-0665018 
Entity Incorporation, State or Country CodeDE 
Entity Address, Address Line One2727 North 3rd Street 
Entity Address, Address Line TwoSuite 201 
Entity Address, City or TownPhoenix 
Entity Address, State or ProvinceAZ 
Entity Address, Postal Zip Code85004 
City Area Code833 
Local Phone Number867-6337 
Entity Current Reporting StatusYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 95,041,184

View differences made from one quarter to another to evaluate Item 9 Labs Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Item 9 Labs Corp..

Continue

Assess how Item 9 Labs Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Item 9 Labs Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Cover
Condensed Consolidated Balance Sheets (Unaudited)
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
Unaudited Condensed Consolidated Statements Of Cash Flows
Unaudited Condensed Consolidated Statements Of Changes In Stockholders' Equity
Unaudited Condensed Consolidated Statements Of Operations
Antidilutive Shares Excluded From Calculation Of Diluted Net Loss Per Share
Assumptions Used To Estimate Fair Value Of Stock Options
Assumptions Used To Estimate Fair Value Of Warrants
Convertible Notes Payable
Future Lease Payments
Future Minimum Payments Of Company's Convertible Debt Obligations
Future Minimum Payments Of Company's Notes Payable Obligations
Inventory
Note 1 - Description Of Business And Summary Of Significant Accounting Policies
Note 1 - Description Of Business And Summary Of Significant Accounting Policies (Details Narrative)
Note 1 - Description Of Business And Summary Of Significant Accounting Policies (Policies)
Note 1 - Description Of Business And Summary Of Significant Accounting Policies (Tables)
Note 10 - Stockholders' Equity
Note 10 - Stockholders' Equity (Details Narrative)
Note 10 - Stockholders' Equity (Tables)
Note 11 ??? Segment Information
Note 11 ??? Segment Information (Tables)
Note 12 - Subsequent Events
Note 2 - Going Concern
Note 3 ??? Inventory
Note 3 ??? Inventory (Tables)
Note 4 ??? Pending Acquisitions
Note 4 ??? Pending Acquisitions (Details Narrative)
Note 5 - Property And Equipment, Net
Note 5 - Property And Equipment, Net (Details Narrative)
Note 5 - Property And Equipment, Net (Tables)
Note 6 - Debt
Note 6 - Debt (Details Narrative)
Note 6 - Debt (Tables)
Note 7 - Concentrations
Note 8 - Commitments And Contingencies
Note 8 - Commitments And Contingencies (Details Narrative)
Note 8 - Commitments And Contingencies (Tables)
Note 9 - Related Party Transactions
Note 9 - Related Party Transactions (Details Narrative)
Notes Payable
Property And Equipment (Details)
Segment Information
Stock Option Activity (Details)
Summary Of Interest Expense
Warrant Activity

Material Contracts, Statements, Certifications & more

Item 9 Labs Corp. provided additional information to their SEC Filing as exhibits

Ticker: INLB
CIK: 1500123
Form Type: 10-Q Quarterly Report
Accession Number: 0001554795-22-000054
Submitted to the SEC: Mon Feb 14 2022 4:16:10 PM EST
Accepted by the SEC: Mon Feb 14 2022
Period: Friday, December 31, 2021
Industry: Dental Equipment And Supplies

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/inlb/0001554795-22-000054.htm